Renaissance Technologies (RenTech)'s GRCE Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 186,134 shares of Grace Therapeutics, Inc. (GRCE) worth $400,188, representing 0.00% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 8 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in GRCE for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 186,134 shares. Largest reduction occurred in Q2 2026, reducing 243,910 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Grace Therapeutics (GRCE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Grace Therapeutics (GRCE) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +186,134 | New Buy | 186,134 | $2.15 |
| Q2 2026 | -243,910 | Sold Out | 0 | $0.00 |
| Q1 2026 | +114,129 | Add 87.94% | 243,910 | $4.63 |
| Q4 2025 | +45,220 | Add 53.48% | 129,781 | $3.46 |
| Q3 2025 | +56,936 | Add 206.10% | 84,561 | $2.98 |
| Q2 2025 | -14,556 | Reduce 34.51% | 27,625 | $2.97 |
| Q1 2025 | -794 | Reduce 1.85% | 42,181 | $2.28 |
| Q4 2024 | +42,975 | New Buy | 42,975 | $3.74 |
Renaissance Technologies (RenTech)'s Grace Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Grace Therapeutics, Inc. (GRCE) in Q4 2024, acquiring 42,975 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Grace Therapeutics, Inc. (GRCE) for 8 quarters since Q4 2024.
Renaissance Technologies (RenTech)'s largest addition to Grace Therapeutics, Inc. (GRCE) was in Q3 2026, adding 186,134 shares worth $400,188.
According to the latest 13F filing for Q3 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 186,134 shares of Grace Therapeutics, Inc. (GRCE), valued at approximately $400,188.
As of the Q3 2026 filing, Grace Therapeutics, Inc. (GRCE) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Grace Therapeutics, Inc. (GRCE) was 243,910 shares, as reported at the end of Q1 2026.